Ori Biotech CEO Jason C. Foster joined Carolina Ibanez Ventoso, Associate Vice President at the Stifel Virtual Cell Therapy Forum, to discuss scaling up manufacturing to improve business viability and patient access.
Jason’s talk focused on how, by leveraging engineering and automation, we can scale biology, increase throughput and quality, and lower manufacturing costs. But to align companies and investors, it’s essential that investors push for robust CMC and manufacturing strategies from the beginning, prior to clinical entry.
IRO®, our manufacturing platform, can help developers reach their next value inflection point more quickly – increasing their ability to secure future funding or partners with a viable plan to scale. This, in turn, helps advanced therapies to be accessible and affordable for all.